| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 330,0 M € | +0.1% | 329,7 M € | -4.9% | 346,7 M € | +1.4% | 341,8 M € | +6.4% | 321,2 M € | +7.1% | 300,1 M € | -29.2% | 423,9 M € | +132.1% | 182,6 M € | +29.0% | 141,6 M € | -3.1% | 146,1 M € | -0.6% | 147,0 M € | +18.6% | 123,9 M € | +9.3% | 113,4 M € | +4.2% | 108,8 M € | |
| EBITDA | 14,2 M € | +12.5% | 12,6 M € | -3.6% | 13,1 M € | -0.3% | 13,1 M € | -10.1% | 14,6 M € | +59.9% | 9,1 M € | -23.0% | 11,9 M € | -41.5% | 20,3 M € | +136.0% | 8,6 M € | -18.6% | 10,6 M € | -8.1% | 11,5 M € | +57.4% | 7,3 M € | +31.0% | 5,6 M € | -49.3% | 11,0 M € | |
| Operating profit | 12,3 M € | +10.6% | 11,1 M € | +8.3% | 10,3 M € | +13.7% | 9,1 M € | +10.2% | 8,2 M € | +84.1% | 4,5 M € | -39.5% | 7,4 M € | -51.4% | 15,2 M € | +126.3% | 6,7 M € | -24.5% | 8,9 M € | -17.5% | 10,8 M € | +68.1% | 6,4 M € | +73.1% | 3,7 M € | -50.7% | 7,5 M € | |
| Profit/loss | 10,2 M € | +9.0% | 9,4 M € | +21.6% | 7,7 M € | +21.0% | 6,4 M € | +36.3% | 4,7 M € | +123.7% | 2,1 M € | -65.1% | 6,0 M € | -50.7% | 12,2 M € | +259.7% | 3,4 M € | -35.2% | 5,2 M € | -15.1% | 6,2 M € | +64.8% | 3,7 M € | +8.5% | 3,4 M € | -29.0% | 4,8 M € | |
| Equity | 80,2 M € | +14.6% | 69,9 M € | +15.5% | 60,6 M € | +14.6% | 52,9 M € | -35.1% | 81,5 M € | +6.1% | 76,8 M € | -2.4% | 78,7 M € | +49.9% | 52,5 M € | +64.8% | 31,9 M € | +11.9% | 28,5 M € | +22.5% | 23,3 M € | +17.0% | 19,9 M € | -54.5% | 43,6 M € | +8.6% | 40,2 M € | |
| Total assets | 225,6 M € | +13.3% | 199,1 M € | +4.4% | 190,6 M € | +44.4% | 132,0 M € | -31.0% | 191,3 M € | -22.6% | 247,1 M € | -16.1% | 294,7 M € | -22.3% | 379,1 M € | +34.5% | 281,9 M € | +223.9% | 87,0 M € | +3.5% | 84,0 M € | +12.3% | 74,9 M € | -22.7% | 96,8 M € | +9.7% | 88,3 M € | |
| Cash | 2,1 M € | +21.6% | 1,7 M € | -18.3% | 2,1 M € | +16.9% | 1,8 M € | +94.0% | 911,6 k € | +12.7% | 808,5 k € | -45.6% | 1,5 M € | -36.4% | 2,3 M € | +27.9% | 1,8 M € | +177.9% | 657,5 k € | -63.1% | 1,8 M € | -66.1% | 5,3 M € | -69.1% | 17,0 M € | -49.0% | 33,4 M € | |
| Debts | 134,7 M € | +13.9% | 118,2 M € | +0.8% | 117,3 M € | +65.6% | 70,8 M € | -30.7% | 102,2 M € | -37.3% | 163,0 M € | -22.2% | 209,6 M € | -33.5% | 315,1 M € | +30.4% | 241,6 M € | +350.1% | 53,7 M € | -11.2% | 60,4 M € | +10.3% | 54,8 M € | +6.5% | 51,4 M € | +7.8% | 47,7 M € | |
| Staff | 267,5 | 259,1 | 264,6 | 261,8 | 259,4 | 268,6 | 267 | 309,6 | 269,1 | 271,5 | 285,1 | 271,1 | 262 | 266,9 | ||||||||||||||
Public limited company · Machelen (Brab.) · incorporated on 07/06/1984 · 267,5 ETP
Public limited company profitable and well capitalised. Cash position rising (+21.6%).
Solid counterparty for a standard engagement.
JOHNSON & JOHNSON MEDICAL is a Public limited company incorporated in 1984. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 267,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette